Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68071-3154

4 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-3154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

68071 3154 3

68071 3154 3
Label for Cyclobenzaprine HCl 10 mg tablets by NuCare Pharmaceuticals, Inc. The package contains 3 round yellow film-coated tablets debossed with 'IG' on one side and '283' on the other. The label includes dosing instructions, warnings about drowsiness, and storage conditions at 68-77°F. NDC 68071-3154-3.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Chemical structure of Cyclobenzaprine Hydrochloride, showing its molecular formula with aromatic rings and side chains, including a hydrochloride component.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
A table comparing side effect percentages for Cyclobenzaprine Hydrochloride Tablets at 5 mg and 10 mg strengths versus placebo in categories including drowsiness, dry mouth, fatigue, and headache, with corresponding sample sizes for each group.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
A data table comparing the incidence percentages of drowsiness, dry mouth, and dizziness between a clinical study and a surveillance program for Cyclobenzaprine HCl Tablets 10 mg. The table shows higher percentages of these side effects in the clinical study than in the surveillance program.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.